{"gene":"CIT","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2016,"finding":"CITK (citron kinase) controls spindle orientation by regulating astral microtubule dynamics; loss of CITK in mammals and insects leads to abnormal spindle orientation, and ASPM is required to recruit CITK to the spindle pole. CITK overexpression rescues the ASPM loss-of-function spindle orientation phenotype. CITK regulates both astral-MT nucleation and stability.","method":"siRNA knockdown in mouse cortical progenitors and Drosophila, spindle orientation assays, live imaging, low-dose MT-stabilizing drug rescue experiments, co-localization and epistasis analyses","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (KD phenotype, genetic rescue, drug rescue, co-localization) in a single rigorous study with functional readout","pmids":["27562601"],"is_preprint":false},{"year":2016,"finding":"Biallelic loss-of-function splice-site variants in CIT (citron kinase) cause severe autosomal recessive primary microcephaly (MCPH17) in humans. The splice-site variant causes intron retention, predicting disruption of the kinase domain. CIT co-localizes to the midbody ring during cytokinesis; its loss results in defective neurogenic cytokinesis.","method":"Genome-wide homozygosity mapping, whole-exome sequencing, cDNA sequencing of affected individuals to confirm aberrant splicing","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — independently reported in two separate papers (PMID 27519304 and 27503289) with exome sequencing plus functional cDNA validation confirming kinase domain disruption","pmids":["27519304","27503289"],"is_preprint":false},{"year":2005,"finding":"Rho/CRIK (citron kinase) signaling suppresses keratinocyte differentiation; CRIK is selectively down-modulated during differentiation, and its over-activity (via Rho) maintains cells in an undifferentiated state. This suppressing function is coupled with induction of KyoT1/2 (FHL1), a LIM-domain protein that itself suppresses differentiation.","method":"Overexpression and knockdown of CRIK in keratinocyte cell lines, gene expression profiling, epistasis with activated Rho","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD/OE with defined cellular phenotype plus downstream gene-expression epistasis, single lab","pmids":["16061799"],"is_preprint":false},{"year":2017,"finding":"CIT (citron kinase) promotes colon cancer cell growth by regulating the p53 signaling pathway; CIT knockdown induces cell cycle arrest and apoptosis, reduces colony formation in vitro, and reduces tumor growth in xenograft experiments.","method":"siRNA knockdown in colon cancer cell lines, proliferation and colony-formation assays, in vivo xenograft, microarray/bioinformatics analysis implicating p53 pathway","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined cellular and in vivo phenotype plus pathway placement via microarray, single lab","pmids":["29069760"],"is_preprint":false},{"year":2020,"finding":"CIT (citron kinase) promotes bladder cancer cell proliferation and colony formation; knockdown induces cell-cycle arrest and apoptosis in vitro and reduces tumor volume in vivo. Microarray analysis indicates CIT acts through the cell cycle signaling pathway. CIT knockdown also upregulates p53 and RhoA-ROCK signaling mediators.","method":"siRNA/shRNA knockdown in bladder cancer cell lines (5367, T24), cell-cycle analysis, apoptosis assays, xenograft model, microarray expression profiling","journal":"Biomedicine & pharmacotherapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined cellular and in vivo phenotype plus pathway analysis, single lab, two orthogonal readouts","pmids":["31972359"],"is_preprint":false},{"year":2020,"finding":"CIT is regulated post-transcriptionally in bladder cancer by a circRNA_0071196/miRNA-19b-3p/CIT axis; circRNA_0071196 sponges miRNA-19b-3p to upregulate CIT levels. CIT knockdown inhibits proliferation, migration, and colony formation and upregulates p53 and RhoA-ROCK pathway mediators.","method":"Luciferase reporter assay (validating circRNA_0071196–miR-19b-3p and miR-19b-3p–CIT interactions), CIT knockdown in 5637 cells, functional assays (proliferation, migration, colony formation)","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — luciferase reporter plus KD functional assays, single lab; non-coding RNA portion is excluded but the direct CIT knockdown mechanistic findings are included","pmids":["32705161"],"is_preprint":false},{"year":2018,"finding":"Citron kinase (CIT-K) promotes breast cancer cell proliferation, migration, invasion and tumorigenicity in vivo; knockdown reduces colony formation, induces apoptosis and cell-cycle arrest. Microarray analysis shows altered expression of cyclin D1, EGFR, JAK1, TGF-α, mTOR, and other signaling genes after CIT-K silencing.","method":"Lentiviral shRNA knockdown in multiple breast cancer cell lines, Western blot, proliferation/colony/transwell assays, flow cytometry, nude mouse xenograft, microarray","journal":"Clinical & translational oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined in vitro and in vivo phenotypes plus microarray pathway analysis, single lab","pmids":["30565087"],"is_preprint":false},{"year":2020,"finding":"CITK (citron kinase) loss impairs proliferation and induces cytokinesis failure and apoptosis in Group 3/4 medulloblastoma cells. CITK knockdown also causes accumulation of DNA damage and reduced RAD51 nuclear levels, indicating impairment of homologous recombination. Combined CITK knockdown with ionizing radiation or cisplatin strongly reduces growth of all tested medulloblastoma cell lines.","method":"siRNA knockdown in D283, D341, ONS-76, DAOY cells; proliferation assays; DNA damage markers (γH2AX); RAD51 nuclear localization by immunofluorescence; clonogenic survival with IR/cisplatin","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with multiple orthogonal cellular phenotype readouts (cytokinesis failure, DNA damage, HR impairment), single lab","pmids":["32111106"],"is_preprint":false},{"year":2024,"finding":"Both the catalytic (kinase) activity and the scaffolding function of CIT are required for NPC cytokinesis polarity and human corticogenesis. CITKI/KI (kinase-dead) human forebrain organoids lose cytoarchitectural complexity (pseudostratified to simple neuroepithelium) and show defects in NPC cytokinesis polarity and elevated apoptosis, similar to CITFS/FS (loss-of-function) organoids. By contrast, the CitKI/KI mouse model does not phenocopy human microcephaly, whereas CitFS/FS mice do; both exhibit binucleation, DNA damage, and apoptosis.","method":"CRISPR knock-in mouse models (CitKI/KI, CitFS/FS), human forebrain organoids (CITKI/KI and CITFS/FS), live 3D imaging of NPC mitosis, apoptosis assays, cytoarchitecture analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in multiple model systems (mouse and human organoids), with mutagenesis distinguishing catalytic vs scaffolding function, and live imaging of mechanistic phenotype","pmids":["39316437"],"is_preprint":false},{"year":2010,"finding":"Statistical epistasis between CIT SNPs (rs3847960, rs440299, rs10744743) and DISC1/NDEL1 SNPs is associated with schizophrenia risk. The interacting CIT SNPs are proximal to exons encoding the DISC1-interaction domain of CIT, suggesting a functional basis for the genetic interaction.","method":"Machine-learning algorithms (random forest, gradient boosting, Monte Carlo logic regression) plus logistic regression for epistasis in case-control cohort; functional validation by fMRI (prefrontal cortical efficiency on N-back task) in independent healthy-control sample","journal":"Human genetics","confidence":"Low","confidence_rationale":"Tier 4 / Weak — genetic association plus fMRI intermediate phenotype; no direct biochemical or molecular experiment on the CIT protein itself","pmids":["20084519"],"is_preprint":false}],"current_model":"CIT (citron rho-interacting serine/threonine kinase, CITK/CRIK) is a Rho-GTPase effector kinase whose catalytic and scaffolding functions are both required for proper cytokinesis of neural progenitor cells—particularly maintenance of spindle orientation and cytokinesis polarity via regulation of astral microtubule dynamics—with biallelic loss-of-function causing primary microcephaly (MCPH17) in humans; beyond neurogenesis, CITK negatively regulates keratinocyte differentiation through a Rho/CRIK/KyoT1/2 axis, and its overexpression promotes proliferation and survival of multiple cancer cell types (colon, bladder, breast, medulloblastoma) partly through p53 and cell-cycle pathways, with CITK loss also impairing homologous recombination-mediated DNA repair."},"narrative":{"mechanistic_narrative":"CIT (citron rho-interacting serine/threonine kinase, CITK/CRIK) is a kinase that governs the fidelity of neural progenitor cell (NPC) division, with both its catalytic activity and scaffolding function required for cytokinesis polarity and proper human corticogenesis [PMID:39316437]. During mitosis CITK controls spindle orientation by regulating astral microtubule nucleation and stability, and is recruited to the spindle pole by ASPM; its overexpression rescues the spindle-orientation defect caused by ASPM loss [PMID:27562601]. CITK also localizes to the midbody ring during cytokinesis, where its loss produces defective neurogenic cytokinesis [PMID:27519304, PMID:27503289]. Biallelic loss-of-function splice-site variants in CIT that disrupt the kinase domain cause autosomal-recessive primary microcephaly (MCPH17) in humans [PMID:27519304, PMID:27503289], and human kinase-dead forebrain organoids phenocopy the loss-of-function organoid defects (loss of pseudostratified cytoarchitecture, impaired NPC cytokinesis polarity, elevated apoptosis), establishing that catalytic activity is essential in the human context even though it is dispensable in mouse [PMID:39316437]. Beyond neurogenesis, CITK acts in a Rho/CRIK/KyoT1-2 (FHL1) axis to suppress keratinocyte differentiation [PMID:16061799], and its elevated expression promotes proliferation and survival across colon, bladder, breast, and medulloblastoma cells through p53 and cell-cycle pathways [PMID:29069760, PMID:31972359, PMID:30565087]; in medulloblastoma, CITK loss additionally causes cytokinesis failure, DNA-damage accumulation, and reduced nuclear RAD51, impairing homologous-recombination repair [PMID:32111106].","teleology":[{"year":2005,"claim":"Established a signaling role for CITK outside mitosis by showing it transduces Rho signaling to block epithelial differentiation, defining a downstream effector axis.","evidence":"Overexpression/knockdown of CRIK in keratinocyte lines with expression profiling and epistasis with activated Rho","pmids":["16061799"],"confidence":"Medium","gaps":["Mechanism by which CITK induces KyoT1/2 (FHL1) not defined","Whether catalytic activity is required for the differentiation block untested","Single-lab finding without in vivo skin model"]},{"year":2010,"claim":"Raised the question of whether CIT contributes to neuropsychiatric risk by reporting statistical epistasis between CIT and DISC1/NDEL1 variants in schizophrenia.","evidence":"Machine-learning epistasis analysis in a case-control cohort with fMRI intermediate-phenotype validation","pmids":["20084519"],"confidence":"Low","gaps":["No direct biochemical experiment on CIT protein","Genetic association does not establish causal mechanism","DISC1-interaction domain function not biochemically tested"]},{"year":2016,"claim":"Defined a mitotic mechanism for CITK: how dividing cells orient their spindle, showing CITK is recruited to the spindle pole by ASPM to regulate astral microtubule dynamics.","evidence":"siRNA knockdown in mouse cortical progenitors and Drosophila, spindle-orientation assays, live imaging, drug rescue, and epistasis with ASPM","pmids":["27562601"],"confidence":"High","gaps":["Direct substrate at the spindle pole not identified","Molecular basis of ASPM-mediated recruitment unresolved","Whether kinase activity vs scaffolding drives astral-MT regulation not separated here"]},{"year":2016,"claim":"Connected CITK loss to human disease, demonstrating that kinase-domain-disrupting biallelic variants cause primary microcephaly via defective neurogenic cytokinesis.","evidence":"Homozygosity mapping, whole-exome sequencing, and cDNA validation of aberrant splicing in affected individuals","pmids":["27519304","27503289"],"confidence":"High","gaps":["Genetic data alone do not isolate catalytic from scaffolding contributions","Cell-type specificity of the requirement not resolved"]},{"year":2017,"claim":"Extended CITK function to tumor biology, showing its elevated activity supports colon cancer growth through the p53 pathway.","evidence":"siRNA knockdown in colon cancer lines with proliferation, colony-formation, xenograft assays, and microarray pathway placement","pmids":["29069760"],"confidence":"Medium","gaps":["Direct molecular link between CITK and p53 not defined","Whether the effect requires kinase activity untested"]},{"year":2018,"claim":"Generalized the pro-proliferative role of CITK to breast cancer, implicating cell-cycle and growth-signaling effectors.","evidence":"Lentiviral shRNA knockdown across breast cancer lines with proliferation/invasion assays, xenograft, and microarray","pmids":["30565087"],"confidence":"Medium","gaps":["Effectors (cyclin D1, EGFR, JAK1, mTOR) shown as correlative expression changes, not mechanistic targets","No reciprocal gain-of-function validation"]},{"year":2020,"claim":"Reinforced CITK's oncogenic role in bladder cancer and placed it post-transcriptionally downstream of a circRNA/miRNA axis acting on p53 and RhoA-ROCK signaling.","evidence":"Knockdown in bladder cancer lines with cell-cycle/apoptosis assays, xenograft, and luciferase reporters for circRNA_0071196/miR-19b-3p/CIT","pmids":["31972359","32705161"],"confidence":"Medium","gaps":["Direct mechanistic link from CITK to p53/RhoA-ROCK changes not established","Single-lab functional assays"]},{"year":2020,"claim":"Revealed a DNA-repair dimension of CITK function in medulloblastoma, linking its loss to homologous-recombination impairment and radio/chemosensitization.","evidence":"siRNA knockdown in Group 3/4 medulloblastoma lines, γH2AX and RAD51 immunofluorescence, clonogenic survival with IR/cisplatin","pmids":["32111106"],"confidence":"Medium","gaps":["Mechanism connecting CITK to RAD51 nuclear loading unknown","Whether HR defect is secondary to cytokinesis failure not resolved"]},{"year":2024,"claim":"Resolved the long-standing question of whether CITK catalytic activity matters for human brain development, showing both kinase and scaffolding functions are required in human NPCs while the mouse tolerates kinase-dead alleles.","evidence":"CRISPR knock-in mouse models and human forebrain organoids (kinase-dead and loss-of-function), 3D live imaging of NPC mitosis, cytoarchitecture and apoptosis analysis","pmids":["39316437"],"confidence":"High","gaps":["Molecular basis of human-specific catalytic requirement unexplained","Catalytic substrates governing cytokinesis polarity not identified"]},{"year":null,"claim":"The direct phosphorylation substrates of CITK that mediate spindle orientation, cytokinesis polarity, and the p53/HR phenotypes remain unidentified.","evidence":"","pmids":[],"confidence":"High","gaps":["No catalytic substrate mapped to any phenotype","Molecular link between CITK and p53/RAD51 pathways undefined","Structural basis of ASPM recruitment unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,8]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[0]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,1,4,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8]}],"complexes":[],"partners":["ASPM"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O14578","full_name":"Citron Rho-interacting kinase","aliases":["Serine/threonine-protein kinase 21"],"length_aa":2027,"mass_kda":231.4,"function":"Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O14578/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/CIT","classification":"Common Essential","n_dependent_lines":654,"n_total_lines":1208,"dependency_fraction":0.5413907284768212},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CIT","total_profiled":1310},"omim":[{"mim_id":"621140","title":"CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1EE WITH OR WITHOUT IMMUNODEFICIENCY; CDG1EE","url":"https://www.omim.org/entry/621140"},{"mim_id":"618899","title":"MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 2; MAN2B2","url":"https://www.omim.org/entry/618899"},{"mim_id":"617090","title":"MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17","url":"https://www.omim.org/entry/617090"},{"mim_id":"610463","title":"NUS1 DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE SUBUNIT; NUS1","url":"https://www.omim.org/entry/610463"},{"mim_id":"608172","title":"DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS","url":"https://www.omim.org/entry/608172"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":13.4},{"tissue":"lymphoid tissue","ntpm":6.3}],"url":"https://www.proteinatlas.org/search/CIT"},"hgnc":{"alias_symbol":["KIAA0949","STK21","CRIK","CITK"],"prev_symbol":[]},"alphafold":{"accession":"O14578","domains":[{"cath_id":"3.30.200.20","chopping":"41-179_385-393_411-430","consensus_level":"medium","plddt":84.0009,"start":41,"end":430},{"cath_id":"1.10.510.10","chopping":"188-231_248-374","consensus_level":"medium","plddt":89.7535,"start":188,"end":374},{"cath_id":"1.10.287","chopping":"486-611_629-678","consensus_level":"high","plddt":76.5499,"start":486,"end":678},{"cath_id":"3.30.60.20","chopping":"1361-1413","consensus_level":"medium","plddt":71.8168,"start":1361,"end":1413},{"cath_id":"2.30.29.30","chopping":"1444-1567","consensus_level":"medium","plddt":72.5661,"start":1444,"end":1567},{"cath_id":"1.20.5","chopping":"1152-1180","consensus_level":"medium","plddt":71.0641,"start":1152,"end":1180},{"cath_id":"2.40.128","chopping":"1690-1765","consensus_level":"medium","plddt":89.2976,"start":1690,"end":1765}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14578","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14578-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14578-F1-predicted_aligned_error_v6.png","plddt_mean":69.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CIT","jax_strain_url":"https://www.jax.org/strain/search?query=CIT"},"sequence":{"accession":"O14578","fasta_url":"https://rest.uniprot.org/uniprotkb/O14578.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14578/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14578"}},"corpus_meta":[{"pmid":"7929662","id":"PMC_7929662","title":"Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.","date":"1994","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/7929662","citation_count":266,"is_preprint":false},{"pmid":"17353255","id":"PMC_17353255","title":"Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.","date":"2007","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17353255","citation_count":218,"is_preprint":false},{"pmid":"11494398","id":"PMC_11494398","title":"Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.","date":"2001","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11494398","citation_count":201,"is_preprint":false},{"pmid":"11315592","id":"PMC_11315592","title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.","date":"2001","source":"European journal of nuclear medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11315592","citation_count":201,"is_preprint":false},{"pmid":"15375677","id":"PMC_15375677","title":"Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.","date":"2004","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/15375677","citation_count":154,"is_preprint":false},{"pmid":"25033234","id":"PMC_25033234","title":"Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25033234","citation_count":144,"is_preprint":false},{"pmid":"8998140","id":"PMC_8998140","title":"Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.","date":"1997","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8998140","citation_count":137,"is_preprint":false},{"pmid":"9539347","id":"PMC_9539347","title":"Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.","date":"1998","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/9539347","citation_count":119,"is_preprint":false},{"pmid":"11007526","id":"PMC_11007526","title":"Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM.","date":"2000","source":"European journal of nuclear medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11007526","citation_count":118,"is_preprint":false},{"pmid":"9457623","id":"PMC_9457623","title":"Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.","date":"1998","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9457623","citation_count":113,"is_preprint":false},{"pmid":"10704949","id":"PMC_10704949","title":"Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.","date":"2000","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10704949","citation_count":109,"is_preprint":false},{"pmid":"16250023","id":"PMC_16250023","title":"[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/16250023","citation_count":108,"is_preprint":false},{"pmid":"14992979","id":"PMC_14992979","title":"Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.","date":"2004","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14992979","citation_count":103,"is_preprint":false},{"pmid":"15817519","id":"PMC_15817519","title":"Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.","date":"2005","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15817519","citation_count":90,"is_preprint":false},{"pmid":"9629849","id":"PMC_9629849","title":"Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.","date":"1998","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9629849","citation_count":87,"is_preprint":false},{"pmid":"8358345","id":"PMC_8358345","title":"Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.","date":"1993","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/8358345","citation_count":87,"is_preprint":false},{"pmid":"9120429","id":"PMC_9120429","title":"Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.","date":"1997","source":"Journal of neural transmission. Supplementum","url":"https://pubmed.ncbi.nlm.nih.gov/9120429","citation_count":84,"is_preprint":false},{"pmid":"12588911","id":"PMC_12588911","title":"[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.","date":"2003","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12588911","citation_count":83,"is_preprint":false},{"pmid":"20084519","id":"PMC_20084519","title":"Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20084519","citation_count":81,"is_preprint":false},{"pmid":"9781531","id":"PMC_9781531","title":"Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity.","date":"1998","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9781531","citation_count":69,"is_preprint":false},{"pmid":"24779862","id":"PMC_24779862","title":"[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.","date":"2014","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24779862","citation_count":67,"is_preprint":false},{"pmid":"21498527","id":"PMC_21498527","title":"Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.","date":"2011","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21498527","citation_count":63,"is_preprint":false},{"pmid":"27562601","id":"PMC_27562601","title":"ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules.","date":"2016","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/27562601","citation_count":58,"is_preprint":false},{"pmid":"11180497","id":"PMC_11180497","title":"Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.","date":"2001","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11180497","citation_count":55,"is_preprint":false},{"pmid":"17704252","id":"PMC_17704252","title":"Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.","date":"2007","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17704252","citation_count":54,"is_preprint":false},{"pmid":"17712282","id":"PMC_17712282","title":"[123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.","date":"2007","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/17712282","citation_count":53,"is_preprint":false},{"pmid":"9013795","id":"PMC_9013795","title":"Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain.","date":"1996","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9013795","citation_count":48,"is_preprint":false},{"pmid":"27519304","id":"PMC_27519304","title":"CIT, a gene involved in neurogenic cytokinesis, is mutated in human primary microcephaly.","date":"2016","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27519304","citation_count":47,"is_preprint":false},{"pmid":"9613734","id":"PMC_9613734","title":"123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.","date":"1998","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/9613734","citation_count":47,"is_preprint":false},{"pmid":"16197476","id":"PMC_16197476","title":"Isolation, cloning and allergenic reactivity of natural profilin Cit s 2, a major orange allergen.","date":"2005","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/16197476","citation_count":46,"is_preprint":false},{"pmid":"15596756","id":"PMC_15596756","title":"Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease.","date":"2004","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15596756","citation_count":46,"is_preprint":false},{"pmid":"18759353","id":"PMC_18759353","title":"[123I]FP-CIT SPET imaging in drug-induced Parkinsonism.","date":"2008","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/18759353","citation_count":43,"is_preprint":false},{"pmid":"18675996","id":"PMC_18675996","title":"[123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism.","date":"2008","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18675996","citation_count":41,"is_preprint":false},{"pmid":"12482072","id":"PMC_12482072","title":"Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.","date":"2002","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/12482072","citation_count":41,"is_preprint":false},{"pmid":"18785639","id":"PMC_18785639","title":"Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy.","date":"2008","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/18785639","citation_count":40,"is_preprint":false},{"pmid":"16521162","id":"PMC_16521162","title":"Germin-like protein Cit s 1 and profilin Cit s 2 are major allergens in orange (Citrus sinensis) fruits.","date":"2006","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/16521162","citation_count":39,"is_preprint":false},{"pmid":"26780619","id":"PMC_26780619","title":"Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.","date":"2016","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/26780619","citation_count":38,"is_preprint":false},{"pmid":"12732687","id":"PMC_12732687","title":"Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.","date":"2003","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12732687","citation_count":36,"is_preprint":false},{"pmid":"15830229","id":"PMC_15830229","title":"Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.","date":"2005","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15830229","citation_count":34,"is_preprint":false},{"pmid":"14712338","id":"PMC_14712338","title":"123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia.","date":"2004","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14712338","citation_count":34,"is_preprint":false},{"pmid":"36721229","id":"PMC_36721229","title":"GPR109A controls neutrophil extracellular traps formation and improve early sepsis by regulating ROS/PAD4/Cit-H3 signal axis.","date":"2023","source":"Experimental hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36721229","citation_count":33,"is_preprint":false},{"pmid":"17716921","id":"PMC_17716921","title":"Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.","date":"2007","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/17716921","citation_count":33,"is_preprint":false},{"pmid":"27503289","id":"PMC_27503289","title":"Mutations in CIT, encoding citron rho-interacting serine/threonine kinase, cause severe primary microcephaly in humans.","date":"2016","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27503289","citation_count":31,"is_preprint":false},{"pmid":"21147345","id":"PMC_21147345","title":"Citrinin (CIT) determination in rice samples using a micro fluidic electrochemical immunosensor.","date":"2010","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/21147345","citation_count":31,"is_preprint":false},{"pmid":"17053905","id":"PMC_17053905","title":"Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.","date":"2006","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/17053905","citation_count":31,"is_preprint":false},{"pmid":"16061799","id":"PMC_16061799","title":"Negative control of keratinocyte differentiation by Rho/CRIK signaling coupled with up-regulation of KyoT1/2 (FHL1) expression.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16061799","citation_count":27,"is_preprint":false},{"pmid":"25819144","id":"PMC_25819144","title":"Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.","date":"2015","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25819144","citation_count":27,"is_preprint":false},{"pmid":"9466362","id":"PMC_9466362","title":"Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.","date":"1998","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/9466362","citation_count":26,"is_preprint":false},{"pmid":"22727453","id":"PMC_22727453","title":"[¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism.","date":"2012","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/22727453","citation_count":25,"is_preprint":false},{"pmid":"23758882","id":"PMC_23758882","title":"High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats.","date":"2013","source":"EJNMMI research","url":"https://pubmed.ncbi.nlm.nih.gov/23758882","citation_count":25,"is_preprint":false},{"pmid":"27480759","id":"PMC_27480759","title":"123I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies.","date":"2016","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/27480759","citation_count":24,"is_preprint":false},{"pmid":"16357490","id":"PMC_16357490","title":"Orange germin-like glycoprotein Cit s 1: an equivocal allergen.","date":"2005","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16357490","citation_count":24,"is_preprint":false},{"pmid":"38031350","id":"PMC_38031350","title":"Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases.","date":"2023","source":"mAbs","url":"https://pubmed.ncbi.nlm.nih.gov/38031350","citation_count":23,"is_preprint":false},{"pmid":"32705161","id":"PMC_32705161","title":"Novel circRNA_0071196/miRNA‑19b‑3p/CIT axis is associated with proliferation and migration of bladder cancer.","date":"2020","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32705161","citation_count":22,"is_preprint":false},{"pmid":"21989394","id":"PMC_21989394","title":"CcpA represses the expression of the divergent cit operons of Enterococcus faecalis through multiple cre sites.","date":"2011","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21989394","citation_count":21,"is_preprint":false},{"pmid":"25504429","id":"PMC_25504429","title":"Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.","date":"2014","source":"European radiology","url":"https://pubmed.ncbi.nlm.nih.gov/25504429","citation_count":21,"is_preprint":false},{"pmid":"11748734","id":"PMC_11748734","title":"Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.","date":"2001","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/11748734","citation_count":21,"is_preprint":false},{"pmid":"29069760","id":"PMC_29069760","title":"Up-regulation of CIT promotes the growth of colon cancer cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29069760","citation_count":20,"is_preprint":false},{"pmid":"23903558","id":"PMC_23903558","title":"¹²³I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools.","date":"2013","source":"Nuclear medicine communications","url":"https://pubmed.ncbi.nlm.nih.gov/23903558","citation_count":20,"is_preprint":false},{"pmid":"28178904","id":"PMC_28178904","title":"Cit/CuS@Fe3O4-based and enzyme-responsive magnetic nanoparticles for tumor chemotherapy, photothermal, and photodynamic therapy.","date":"2016","source":"Journal of biomaterials applications","url":"https://pubmed.ncbi.nlm.nih.gov/28178904","citation_count":18,"is_preprint":false},{"pmid":"9037772","id":"PMC_9037772","title":"A novel bend of DNA CIT: changeable bending-center sites of an intrinsic curvature under temperature conditions.","date":"1997","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/9037772","citation_count":18,"is_preprint":false},{"pmid":"32682292","id":"PMC_32682292","title":"BDNF levels and nigrostriatal degeneration in \"drug naïve\" Parkinson's disease patients. An \"in vivo\" study using I-123-FP-CIT SPECT.","date":"2020","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32682292","citation_count":18,"is_preprint":false},{"pmid":"17149727","id":"PMC_17149727","title":"Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study.","date":"2007","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/17149727","citation_count":18,"is_preprint":false},{"pmid":"20628840","id":"PMC_20628840","title":"Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma.","date":"2010","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/20628840","citation_count":18,"is_preprint":false},{"pmid":"32111106","id":"PMC_32111106","title":"CITK Loss Inhibits Growth of Group 3 and Group 4 Medulloblastoma Cells and Sensitizes Them to DNA-Damaging Agents.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32111106","citation_count":17,"is_preprint":false},{"pmid":"17095532","id":"PMC_17095532","title":"Molecular and immunological characterization of the glycosylated orange allergen Cit s 1.","date":"2006","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17095532","citation_count":17,"is_preprint":false},{"pmid":"33542085","id":"PMC_33542085","title":"123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.","date":"2021","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33542085","citation_count":17,"is_preprint":false},{"pmid":"15080991","id":"PMC_15080991","title":"Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).","date":"2004","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/15080991","citation_count":17,"is_preprint":false},{"pmid":"26978429","id":"PMC_26978429","title":"FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.","date":"2016","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26978429","citation_count":16,"is_preprint":false},{"pmid":"36288409","id":"PMC_36288409","title":"Dual-phase 18 F-FP-CIT positron emission tomography and cardiac 123 I-MIBG scintigraphy of Parkinson's disease patients with GBA mutations: evidence of the body-first type?","date":"2022","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36288409","citation_count":15,"is_preprint":false},{"pmid":"25088104","id":"PMC_25088104","title":"Automated quantification with BRASS reduces equivocal reporting of DaTSCAN (123I-FP-CIT) SPECT studies.","date":"2014","source":"Nuclear medicine review. Central & Eastern Europe","url":"https://pubmed.ncbi.nlm.nih.gov/25088104","citation_count":15,"is_preprint":false},{"pmid":"25405287","id":"PMC_25405287","title":"The antiosteoporotic activity of central-icaritin (CIT) on bone metabolism of ovariectomized rats.","date":"2014","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/25405287","citation_count":14,"is_preprint":false},{"pmid":"20499937","id":"PMC_20499937","title":"Proteome from lemon fruit flavedo reveals that this tissue produces high amounts of the Cit s1 germin-like isoforms.","date":"2010","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20499937","citation_count":14,"is_preprint":false},{"pmid":"16525925","id":"PMC_16525925","title":"[Study of presynaptic nigrostriatal pathway by 123-I-FD-CIT-SPECT (DatSCAN SPECT) in primary orthostatic tremor].","date":"2006","source":"Neurologia (Barcelona, Spain)","url":"https://pubmed.ncbi.nlm.nih.gov/16525925","citation_count":14,"is_preprint":false},{"pmid":"11169768","id":"PMC_11169768","title":"Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus.","date":"2001","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11169768","citation_count":13,"is_preprint":false},{"pmid":"30687897","id":"PMC_30687897","title":"Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT.","date":"2019","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30687897","citation_count":13,"is_preprint":false},{"pmid":"20628071","id":"PMC_20628071","title":"C-It: a knowledge database for tissue-enriched genes.","date":"2010","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20628071","citation_count":13,"is_preprint":false},{"pmid":"38455061","id":"PMC_38455061","title":"Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38455061","citation_count":12,"is_preprint":false},{"pmid":"30565087","id":"PMC_30565087","title":"Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.","date":"2018","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/30565087","citation_count":12,"is_preprint":false},{"pmid":"31972359","id":"PMC_31972359","title":"Down-regulation of CIT can inhibit the growth of human bladder cancer cells.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31972359","citation_count":12,"is_preprint":false},{"pmid":"9380528","id":"PMC_9380528","title":"[Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].","date":"1997","source":"Nuklearmedizin. Nuclear medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9380528","citation_count":12,"is_preprint":false},{"pmid":"29163872","id":"PMC_29163872","title":"CIT-7, a crystalline, molecular sieve with pores bounded by 8 and 10-membered rings.","date":"2015","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/29163872","citation_count":12,"is_preprint":false},{"pmid":"23631981","id":"PMC_23631981","title":"Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry.","date":"2013","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/23631981","citation_count":11,"is_preprint":false},{"pmid":"39316437","id":"PMC_39316437","title":"Modeling primary microcephaly with human brain organoids reveals fundamental roles of CIT kinase activity.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/39316437","citation_count":10,"is_preprint":false},{"pmid":"35040375","id":"PMC_35040375","title":"Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors.","date":"2022","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/35040375","citation_count":10,"is_preprint":false},{"pmid":"7904043","id":"PMC_7904043","title":"Characterization of the cit-1 gene from Neurospora crassa encoding the mitochondrial form of citrate synthase.","date":"1994","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/7904043","citation_count":10,"is_preprint":false},{"pmid":"17910836","id":"PMC_17910836","title":"[Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].","date":"2007","source":"Revista espanola de medicina nuclear","url":"https://pubmed.ncbi.nlm.nih.gov/17910836","citation_count":10,"is_preprint":false},{"pmid":"27148001","id":"PMC_27148001","title":"Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response.","date":"2016","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27148001","citation_count":9,"is_preprint":false},{"pmid":"27814458","id":"PMC_27814458","title":"Test-retest reproducibility of extrastriatal binding with 123I-FP-CIT SPECT in healthy male subjects.","date":"2016","source":"Psychiatry research. Neuroimaging","url":"https://pubmed.ncbi.nlm.nih.gov/27814458","citation_count":8,"is_preprint":false},{"pmid":"30288781","id":"PMC_30288781","title":"123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.","date":"2018","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/30288781","citation_count":8,"is_preprint":false},{"pmid":"29476250","id":"PMC_29476250","title":"Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective 123I-FP-CIT SPECT imaging genetic study.","date":"2018","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/29476250","citation_count":8,"is_preprint":false},{"pmid":"29063467","id":"PMC_29063467","title":"Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson's disease.","date":"2017","source":"Japanese journal of radiology","url":"https://pubmed.ncbi.nlm.nih.gov/29063467","citation_count":8,"is_preprint":false},{"pmid":"35801711","id":"PMC_35801711","title":"18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom.","date":"2022","source":"Prion","url":"https://pubmed.ncbi.nlm.nih.gov/35801711","citation_count":8,"is_preprint":false},{"pmid":"8965201","id":"PMC_8965201","title":"Visualization of ischemic insult in caudate putamen with beta-CIT.","date":"1996","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8965201","citation_count":8,"is_preprint":false},{"pmid":"9826232","id":"PMC_9826232","title":"Enhancement of in vivo binding of [123I]beta-CIT by MK-801 in rat brain.","date":"1998","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9826232","citation_count":8,"is_preprint":false},{"pmid":"32904219","id":"PMC_32904219","title":"An innovative genosensor for the monitoring of Leishmania spp sequence using binding of pDNA to cDNA based on Cit-AgNPs.","date":"2020","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/32904219","citation_count":8,"is_preprint":false},{"pmid":"38693679","id":"PMC_38693679","title":"I123-FP-CIT (DaTSCAN) SPECT beyond the Most Common Causes of Parkinsonism: A Systematic Review.","date":"2024","source":"Movement disorders clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/38693679","citation_count":7,"is_preprint":false},{"pmid":"22527785","id":"PMC_22527785","title":"Cerebrotendinous xanthomatosis presenting with asymmetric parkinsonism: a case with I-123-FP-CIT SPECT imaging.","date":"2012","source":"Acta neurologica Belgica","url":"https://pubmed.ncbi.nlm.nih.gov/22527785","citation_count":7,"is_preprint":false},{"pmid":"26126942","id":"PMC_26126942","title":"Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography.","date":"2015","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26126942","citation_count":7,"is_preprint":false},{"pmid":"22827895","id":"PMC_22827895","title":"Visualizing dopamine transporter integrity with iodine-123-FP-CIT SPECT in combination with high resolution MRI in the brain of the common marmoset monkey.","date":"2012","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/22827895","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55544,"output_tokens":2819,"usd":0.104458,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10210,"output_tokens":3183,"usd":0.065312,"stage2_stop_reason":"end_turn"},"total_usd":0.16977,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"CITK (citron kinase) controls spindle orientation by regulating astral microtubule dynamics; loss of CITK in mammals and insects leads to abnormal spindle orientation, and ASPM is required to recruit CITK to the spindle pole. CITK overexpression rescues the ASPM loss-of-function spindle orientation phenotype. CITK regulates both astral-MT nucleation and stability.\",\n      \"method\": \"siRNA knockdown in mouse cortical progenitors and Drosophila, spindle orientation assays, live imaging, low-dose MT-stabilizing drug rescue experiments, co-localization and epistasis analyses\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (KD phenotype, genetic rescue, drug rescue, co-localization) in a single rigorous study with functional readout\",\n      \"pmids\": [\"27562601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Biallelic loss-of-function splice-site variants in CIT (citron kinase) cause severe autosomal recessive primary microcephaly (MCPH17) in humans. The splice-site variant causes intron retention, predicting disruption of the kinase domain. CIT co-localizes to the midbody ring during cytokinesis; its loss results in defective neurogenic cytokinesis.\",\n      \"method\": \"Genome-wide homozygosity mapping, whole-exome sequencing, cDNA sequencing of affected individuals to confirm aberrant splicing\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independently reported in two separate papers (PMID 27519304 and 27503289) with exome sequencing plus functional cDNA validation confirming kinase domain disruption\",\n      \"pmids\": [\"27519304\", \"27503289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Rho/CRIK (citron kinase) signaling suppresses keratinocyte differentiation; CRIK is selectively down-modulated during differentiation, and its over-activity (via Rho) maintains cells in an undifferentiated state. This suppressing function is coupled with induction of KyoT1/2 (FHL1), a LIM-domain protein that itself suppresses differentiation.\",\n      \"method\": \"Overexpression and knockdown of CRIK in keratinocyte cell lines, gene expression profiling, epistasis with activated Rho\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD/OE with defined cellular phenotype plus downstream gene-expression epistasis, single lab\",\n      \"pmids\": [\"16061799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CIT (citron kinase) promotes colon cancer cell growth by regulating the p53 signaling pathway; CIT knockdown induces cell cycle arrest and apoptosis, reduces colony formation in vitro, and reduces tumor growth in xenograft experiments.\",\n      \"method\": \"siRNA knockdown in colon cancer cell lines, proliferation and colony-formation assays, in vivo xenograft, microarray/bioinformatics analysis implicating p53 pathway\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined cellular and in vivo phenotype plus pathway placement via microarray, single lab\",\n      \"pmids\": [\"29069760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CIT (citron kinase) promotes bladder cancer cell proliferation and colony formation; knockdown induces cell-cycle arrest and apoptosis in vitro and reduces tumor volume in vivo. Microarray analysis indicates CIT acts through the cell cycle signaling pathway. CIT knockdown also upregulates p53 and RhoA-ROCK signaling mediators.\",\n      \"method\": \"siRNA/shRNA knockdown in bladder cancer cell lines (5367, T24), cell-cycle analysis, apoptosis assays, xenograft model, microarray expression profiling\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined cellular and in vivo phenotype plus pathway analysis, single lab, two orthogonal readouts\",\n      \"pmids\": [\"31972359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CIT is regulated post-transcriptionally in bladder cancer by a circRNA_0071196/miRNA-19b-3p/CIT axis; circRNA_0071196 sponges miRNA-19b-3p to upregulate CIT levels. CIT knockdown inhibits proliferation, migration, and colony formation and upregulates p53 and RhoA-ROCK pathway mediators.\",\n      \"method\": \"Luciferase reporter assay (validating circRNA_0071196–miR-19b-3p and miR-19b-3p–CIT interactions), CIT knockdown in 5637 cells, functional assays (proliferation, migration, colony formation)\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — luciferase reporter plus KD functional assays, single lab; non-coding RNA portion is excluded but the direct CIT knockdown mechanistic findings are included\",\n      \"pmids\": [\"32705161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Citron kinase (CIT-K) promotes breast cancer cell proliferation, migration, invasion and tumorigenicity in vivo; knockdown reduces colony formation, induces apoptosis and cell-cycle arrest. Microarray analysis shows altered expression of cyclin D1, EGFR, JAK1, TGF-α, mTOR, and other signaling genes after CIT-K silencing.\",\n      \"method\": \"Lentiviral shRNA knockdown in multiple breast cancer cell lines, Western blot, proliferation/colony/transwell assays, flow cytometry, nude mouse xenograft, microarray\",\n      \"journal\": \"Clinical & translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined in vitro and in vivo phenotypes plus microarray pathway analysis, single lab\",\n      \"pmids\": [\"30565087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CITK (citron kinase) loss impairs proliferation and induces cytokinesis failure and apoptosis in Group 3/4 medulloblastoma cells. CITK knockdown also causes accumulation of DNA damage and reduced RAD51 nuclear levels, indicating impairment of homologous recombination. Combined CITK knockdown with ionizing radiation or cisplatin strongly reduces growth of all tested medulloblastoma cell lines.\",\n      \"method\": \"siRNA knockdown in D283, D341, ONS-76, DAOY cells; proliferation assays; DNA damage markers (γH2AX); RAD51 nuclear localization by immunofluorescence; clonogenic survival with IR/cisplatin\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with multiple orthogonal cellular phenotype readouts (cytokinesis failure, DNA damage, HR impairment), single lab\",\n      \"pmids\": [\"32111106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Both the catalytic (kinase) activity and the scaffolding function of CIT are required for NPC cytokinesis polarity and human corticogenesis. CITKI/KI (kinase-dead) human forebrain organoids lose cytoarchitectural complexity (pseudostratified to simple neuroepithelium) and show defects in NPC cytokinesis polarity and elevated apoptosis, similar to CITFS/FS (loss-of-function) organoids. By contrast, the CitKI/KI mouse model does not phenocopy human microcephaly, whereas CitFS/FS mice do; both exhibit binucleation, DNA damage, and apoptosis.\",\n      \"method\": \"CRISPR knock-in mouse models (CitKI/KI, CitFS/FS), human forebrain organoids (CITKI/KI and CITFS/FS), live 3D imaging of NPC mitosis, apoptosis assays, cytoarchitecture analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in multiple model systems (mouse and human organoids), with mutagenesis distinguishing catalytic vs scaffolding function, and live imaging of mechanistic phenotype\",\n      \"pmids\": [\"39316437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Statistical epistasis between CIT SNPs (rs3847960, rs440299, rs10744743) and DISC1/NDEL1 SNPs is associated with schizophrenia risk. The interacting CIT SNPs are proximal to exons encoding the DISC1-interaction domain of CIT, suggesting a functional basis for the genetic interaction.\",\n      \"method\": \"Machine-learning algorithms (random forest, gradient boosting, Monte Carlo logic regression) plus logistic regression for epistasis in case-control cohort; functional validation by fMRI (prefrontal cortical efficiency on N-back task) in independent healthy-control sample\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — genetic association plus fMRI intermediate phenotype; no direct biochemical or molecular experiment on the CIT protein itself\",\n      \"pmids\": [\"20084519\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CIT (citron rho-interacting serine/threonine kinase, CITK/CRIK) is a Rho-GTPase effector kinase whose catalytic and scaffolding functions are both required for proper cytokinesis of neural progenitor cells—particularly maintenance of spindle orientation and cytokinesis polarity via regulation of astral microtubule dynamics—with biallelic loss-of-function causing primary microcephaly (MCPH17) in humans; beyond neurogenesis, CITK negatively regulates keratinocyte differentiation through a Rho/CRIK/KyoT1/2 axis, and its overexpression promotes proliferation and survival of multiple cancer cell types (colon, bladder, breast, medulloblastoma) partly through p53 and cell-cycle pathways, with CITK loss also impairing homologous recombination-mediated DNA repair.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CIT (citron rho-interacting serine/threonine kinase, CITK/CRIK) is a kinase that governs the fidelity of neural progenitor cell (NPC) division, with both its catalytic activity and scaffolding function required for cytokinesis polarity and proper human corticogenesis [#8]. During mitosis CITK controls spindle orientation by regulating astral microtubule nucleation and stability, and is recruited to the spindle pole by ASPM; its overexpression rescues the spindle-orientation defect caused by ASPM loss [#0]. CITK also localizes to the midbody ring during cytokinesis, where its loss produces defective neurogenic cytokinesis [#1]. Biallelic loss-of-function splice-site variants in CIT that disrupt the kinase domain cause autosomal-recessive primary microcephaly (MCPH17) in humans [#1], and human kinase-dead forebrain organoids phenocopy the loss-of-function organoid defects (loss of pseudostratified cytoarchitecture, impaired NPC cytokinesis polarity, elevated apoptosis), establishing that catalytic activity is essential in the human context even though it is dispensable in mouse [#8]. Beyond neurogenesis, CITK acts in a Rho/CRIK/KyoT1-2 (FHL1) axis to suppress keratinocyte differentiation [#2], and its elevated expression promotes proliferation and survival across colon, bladder, breast, and medulloblastoma cells through p53 and cell-cycle pathways [#3, #4, #6]; in medulloblastoma, CITK loss additionally causes cytokinesis failure, DNA-damage accumulation, and reduced nuclear RAD51, impairing homologous-recombination repair [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established a signaling role for CITK outside mitosis by showing it transduces Rho signaling to block epithelial differentiation, defining a downstream effector axis.\",\n      \"evidence\": \"Overexpression/knockdown of CRIK in keratinocyte lines with expression profiling and epistasis with activated Rho\",\n      \"pmids\": [\"16061799\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which CITK induces KyoT1/2 (FHL1) not defined\", \"Whether catalytic activity is required for the differentiation block untested\", \"Single-lab finding without in vivo skin model\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Raised the question of whether CIT contributes to neuropsychiatric risk by reporting statistical epistasis between CIT and DISC1/NDEL1 variants in schizophrenia.\",\n      \"evidence\": \"Machine-learning epistasis analysis in a case-control cohort with fMRI intermediate-phenotype validation\",\n      \"pmids\": [\"20084519\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct biochemical experiment on CIT protein\", \"Genetic association does not establish causal mechanism\", \"DISC1-interaction domain function not biochemically tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined a mitotic mechanism for CITK: how dividing cells orient their spindle, showing CITK is recruited to the spindle pole by ASPM to regulate astral microtubule dynamics.\",\n      \"evidence\": \"siRNA knockdown in mouse cortical progenitors and Drosophila, spindle-orientation assays, live imaging, drug rescue, and epistasis with ASPM\",\n      \"pmids\": [\"27562601\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct substrate at the spindle pole not identified\", \"Molecular basis of ASPM-mediated recruitment unresolved\", \"Whether kinase activity vs scaffolding drives astral-MT regulation not separated here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected CITK loss to human disease, demonstrating that kinase-domain-disrupting biallelic variants cause primary microcephaly via defective neurogenic cytokinesis.\",\n      \"evidence\": \"Homozygosity mapping, whole-exome sequencing, and cDNA validation of aberrant splicing in affected individuals\",\n      \"pmids\": [\"27519304\", \"27503289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genetic data alone do not isolate catalytic from scaffolding contributions\", \"Cell-type specificity of the requirement not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended CITK function to tumor biology, showing its elevated activity supports colon cancer growth through the p53 pathway.\",\n      \"evidence\": \"siRNA knockdown in colon cancer lines with proliferation, colony-formation, xenograft assays, and microarray pathway placement\",\n      \"pmids\": [\"29069760\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular link between CITK and p53 not defined\", \"Whether the effect requires kinase activity untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Generalized the pro-proliferative role of CITK to breast cancer, implicating cell-cycle and growth-signaling effectors.\",\n      \"evidence\": \"Lentiviral shRNA knockdown across breast cancer lines with proliferation/invasion assays, xenograft, and microarray\",\n      \"pmids\": [\"30565087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Effectors (cyclin D1, EGFR, JAK1, mTOR) shown as correlative expression changes, not mechanistic targets\", \"No reciprocal gain-of-function validation\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Reinforced CITK's oncogenic role in bladder cancer and placed it post-transcriptionally downstream of a circRNA/miRNA axis acting on p53 and RhoA-ROCK signaling.\",\n      \"evidence\": \"Knockdown in bladder cancer lines with cell-cycle/apoptosis assays, xenograft, and luciferase reporters for circRNA_0071196/miR-19b-3p/CIT\",\n      \"pmids\": [\"31972359\", \"32705161\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanistic link from CITK to p53/RhoA-ROCK changes not established\", \"Single-lab functional assays\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a DNA-repair dimension of CITK function in medulloblastoma, linking its loss to homologous-recombination impairment and radio/chemosensitization.\",\n      \"evidence\": \"siRNA knockdown in Group 3/4 medulloblastoma lines, \\u03b3H2AX and RAD51 immunofluorescence, clonogenic survival with IR/cisplatin\",\n      \"pmids\": [\"32111106\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting CITK to RAD51 nuclear loading unknown\", \"Whether HR defect is secondary to cytokinesis failure not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved the long-standing question of whether CITK catalytic activity matters for human brain development, showing both kinase and scaffolding functions are required in human NPCs while the mouse tolerates kinase-dead alleles.\",\n      \"evidence\": \"CRISPR knock-in mouse models and human forebrain organoids (kinase-dead and loss-of-function), 3D live imaging of NPC mitosis, cytoarchitecture and apoptosis analysis\",\n      \"pmids\": [\"39316437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of human-specific catalytic requirement unexplained\", \"Catalytic substrates governing cytokinesis polarity not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct phosphorylation substrates of CITK that mediate spindle orientation, cytokinesis polarity, and the p53/HR phenotypes remain unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No catalytic substrate mapped to any phenotype\", \"Molecular link between CITK and p53/RAD51 pathways undefined\", \"Structural basis of ASPM recruitment unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 1, 4, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ASPM\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}